logo

Acasti Pharma, Inc. (ACST)



Trade ACST now with
  Date
  Headline
9/29/2020 7:17:26 AM Acasti Pharma Begins Formal Process To Explore And Evaluate Strategic Alternatives
8/31/2020 7:06:37 AM Acasti Pharma Says Phase 3 TRILOGY 2 Study Did Not Meet Its Primary Endpoint
7/31/2020 8:27:56 AM Acasti Submits Statistical Analysis Plan To FDA; Remains On Track To Report TRILOGY 2 Topline Data On Or About Aug 31
6/19/2020 8:08:27 AM Acasti Pharma: FDA Provides Written Response To Type C Meeting Request And Briefing Package
1/13/2020 6:13:53 AM Axsome Therapeutics Enters License Agreement With Pfizer For Reboxetine
1/13/2020 6:11:14 AM Acasti Pharma: TRILOGY 1 Phase 3 Trial Of CaPre Did Not Reach Statistical Significance
1/13/2020 6:10:50 AM Acasti Pharma Says TRILOGY 1 Phase 3 Trial Of CaPre Did Not Reach Statistical Significance